Literature DB >> 19193648

A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligands.

Kelly L Walton1, Yogeshwar Makanji, Matthew C Wilce, Karen L Chan, David M Robertson, Craig A Harrison.   

Abstract

The assembly and secretion of transforming growth factor beta superfamily ligands is dependent upon non-covalent interactions between their pro- and mature domains. Despite the importance of this interaction, little is known regarding the underlying regulatory mechanisms. In this study, the binding interface between the pro- and mature domains of the inhibin alpha-subunit was characterized using in vitro mutagenesis. Three hydrophobic residues near the N terminus of the prodomain (Leu(30), Phe(37), Leu(41)) were identified that, when mutated to alanine, disrupted heterodimer assembly and secretion. It is postulated that these residues mediate dimerization by interacting non-covalently with hydrophobic residues (Phe(271), Ile(280), Pro(283), Leu(338), and Val(340)) on the outer convex surface of the mature alpha-subunit. Homology modeling indicated that these mature residues are located at the interface between two beta-sheets of the alpha-subunit and that their side chains form a hydrophobic packing core. Mutation of these residues likely disturbs the conformation of this region, thereby disrupting non-covalent interactions with the prodomain. A similar hydrophobic interface was identified spanning the pro- and mature domains of the inhibin beta(A)-subunit. Mutation of key residues, including Ile(62), Leu(66), Phe(329), and Pro(341), across this interface was disruptive for the production of both inhibin A and activin A. In addition, mutation of Ile(62) and Leu(66) in the beta(A)-propeptide reduced its ability to bind, or inhibit the activity of, activin A. Conservation of the identified hydrophobic motifs in the pro- and mature domains of other transforming growth factor beta superfamily ligands suggests that we have identified a common biosynthetic pathway governing dimer assembly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193648      PMCID: PMC2666583          DOI: 10.1074/jbc.M808763200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.

Authors:  Marko Hyytiäinen; Carita Penttinen; Jorma Keski-Oja
Journal:  Crit Rev Clin Lab Sci       Date:  2004       Impact factor: 6.250

2.  Characterization and identification of the inhibitory domain of GDF-8 propeptide.

Authors:  Man-Shiow Jiang; Li-fang Liang; Shusheng Wang; Tamara Ratovitski; James Holmstrom; Christopher Barker; Ronald Stotish
Journal:  Biochem Biophys Res Commun       Date:  2004-03-12       Impact factor: 3.575

3.  The effects of inhibin purified from bovine follicular fluid in several in vitro pituitary cell culture systems.

Authors:  D M Robertson; M S Giacometti; D M de Kretser
Journal:  Mol Cell Endocrinol       Date:  1986-06       Impact factor: 4.102

4.  The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).

Authors:  S Maeda; D D Dean; R Gomez; Z Schwartz; B D Boyan
Journal:  Calcif Tissue Int       Date:  2001-12-21       Impact factor: 4.333

5.  Requirement for activin A and transforming growth factor--beta 1 pro-regions in homodimer assembly.

Authors:  A M Gray; A J Mason
Journal:  Science       Date:  1990-03-16       Impact factor: 47.728

6.  Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide.

Authors:  L E Gentry; M N Lioubin; A F Purchio; H Marquardt
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

7.  Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid.

Authors:  W Vale; J Rivier; J Vaughan; R McClintock; A Corrigan; W Woo; D Karr; J Spiess
Journal:  Nature       Date:  1986 Jun 19-25       Impact factor: 49.962

8.  Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells.

Authors:  L E Gentry; N R Webb; G J Lim; A M Brunner; J E Ranchalis; D R Twardzik; M N Lioubin; H Marquardt; A F Purchio
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

9.  Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene.

Authors:  Elisa Di Pasquale; Paolo Beck-Peccoz; Luca Persani
Journal:  Am J Hum Genet       Date:  2004-05-10       Impact factor: 11.025

10.  Molecular interactions that confer latency to transforming growth factor-beta.

Authors:  Geoffrey D Young; Joanne E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2004-06-18       Impact factor: 5.157

View more
  18 in total

1.  Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.

Authors:  Shaoliang Li; Chisei Shimono; Naoko Norioka; Itsuko Nakano; Tetsuo Okubo; Yoshiko Yagi; Maria Hayashi; Yuya Sato; Hitomi Fujisaki; Shunji Hattori; Nobuo Sugiura; Koji Kimata; Kiyotoshi Sekiguchi
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

Review 2.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

3.  Latent TGF-β structure and activation.

Authors:  Minlong Shi; Jianghai Zhu; Rui Wang; Xing Chen; Lizhi Mi; Thomas Walz; Timothy A Springer
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

4.  Development of novel activin-targeted therapeutics.

Authors:  Justin L Chen; Kelly L Walton; Sara L Al-Musawi; Emily K Kelly; Hongwei Qian; Mylinh La; Louis Lu; George Lovrecz; Mark Ziemann; Ross Lazarus; Assam El-Osta; Paul Gregorevic; Craig A Harrison
Journal:  Mol Ther       Date:  2014-11-17       Impact factor: 11.454

5.  An Extra Arm May Impair the Open Hand.

Authors:  Elizabeth A McGee; Renju S Raj
Journal:  Endocrinology       Date:  2015-08       Impact factor: 4.736

Review 6.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 7.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

8.  Alternative cleavage of the bone morphogenetic protein (BMP), Gbb, produces ligands with distinct developmental functions and receptor preferences.

Authors:  Edward N Anderson; Kristi A Wharton
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

9.  Cumulin, an Oocyte-secreted Heterodimer of the Transforming Growth Factor-β Family, Is a Potent Activator of Granulosa Cells and Improves Oocyte Quality.

Authors:  David G Mottershead; Satoshi Sugimura; Sara L Al-Musawi; Jing-Jie Li; Dulama Richani; Melissa A White; Georgia A Martin; Andrew P Trotta; Lesley J Ritter; Junyan Shi; Thomas D Mueller; Craig A Harrison; Robert B Gilchrist
Journal:  J Biol Chem       Date:  2015-08-08       Impact factor: 5.157

10.  Production, Isolation, and Structural Analysis of Ligands and Receptors of the TGF-β Superfamily.

Authors:  Tao Huang; Andrew P Hinck
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.